How to get a home UVB prescription

Use this page to prepare a direct question for your prescriber and clarify who owns each paperwork step. Your clinician makes the medical decision, and suppliers and plans can require different current forms.

Last updated

Ultraviolet lamps for dermatologic disorders are FDA-classified as Class II devices, and 21 CFR 801.109 defines the federal labeling framework for prescription devices. Those records do not prove the status of a marketplace listing or decide whether a particular device, seller, or transaction complies.

The path to home light therapyFive steps: decide, get prescribed, get it covered, choose your device, track and stay consistent.1DecideHome or clinic,for your life, not in general“Can recurring clinicvisits fit my week?”2Get prescribedWhat to ask at theappointment (US law: Rx)“Would you write a homephototherapy script?”3Get it coveredYour insurer’s policy,and the appeal if denied“Which written rulecontrols my plan?”4Choose a deviceForm factor · current quote· space · support route“Which options shouldI compare?”5Track itSessions, skin response,photos - on your iPhone“The SteadySkin app,private by design.”Each person’s path and timing differ. These five guides organize the questions.

What do you actually ask for?

“Would you write a prescription for home narrowband UVB, and will your office handle the device paperwork?”

It is deliberately two asks in one. The prescription is the medical decision; the paperwork is a separate operational question. Asking both helps identify who owns the next step without assuming the clinic, supplier, or plan will handle it.

If you want to prepare more thoroughly - what the supplier and insurer each need, and what to ask if the answer is no - the full planning guide is at getting your home NB-UVB prescription.

What if your dermatologist pushes back?

These are neutral follow-up questions for several answers a patient might hear.

  • “I’d rather supervise the first course in clinic.” That is a fair clinical position. Ask what information or follow-up would be needed to revisit the question, without presuming that home treatment will become appropriate.
  • “Insurance rarely covers these.” Ask which current written plan policy applies, whether a request can be submitted, and where to obtain an official written decision. Coverage and appeal rights vary by plan and request.
  • “I don’t know the device vendors.” Ask whether the office can review a supplier’s current order form and who should send it. Verify the current form and workflow directly with the clinic and supplier.

Practical tip - not advice

What makes this request easier

Bringing the manufacturer’s current order form can make an unfamiliar vendor less of an administrative hurdle. Office workflows differ, so ask who owns each step rather than assuming the manufacturer or clinic will handle it.

What does the office actually have to do?

The exact documents vary. Two items worth asking about are:

  • A current prescription or supplier order form. Ask the supplier which form and submission route it currently accepts, then ask the office whether it can review that form.
  • Any plan-requested supporting document. If pursuing coverage, ask the plan what it requires and whether the clinic can provide the requested clinical documentation.

Practical tip - not advice

What a prescription request usually involves

Asking the question above at a routine follow-up is often enough to start the process; some offices sign and fax the form the same week. Timelines and paperwork vary by office and are not predicted by another patient’s experience.

Already mid-course at a clinic?

Ask your prescriber whether a change of setting is appropriate and what a safe handoff would require. Bringing the existing record can make that conversation more specific:

  • Your session history from the clinic - dates attended and dates missed, which the phototherapy service can print.
  • Any reaction notes - when your skin reacted, where, and what the clinic did about it.
  • The current plan and most recent response notes, so the new plan starts from what actually happened rather than memory.

Practical tip - not advice

Why people ask about home therapy

A recurring clinic visit schedule can be hard to stay consistent with, especially when a skin reaction pauses treatment and the make-up visits collide with work. Unpredictable time off can make attendance worse than the treatment itself. For many people the schedule, not the treatment, is what prompts the question about home therapy. Your reasons and your plan may be different - that is what the conversation with your prescriber is for.

Want these questions with you in the exam room?

The script and the follow-up questions on this page are on the site’s shared question list, so you can review them from your phone while you wait.

Add these questions to My questions

Hear when SteadySkin is available

SteadySkin currently supports vitiligo. You can use this guide without the app.

We send only your email address and Buttondown’s non-personal embed control. We do not send a topic tag, condition, reading history, or page path, and we never sell your address. You will get a confirmation email - click the link in it to finish joining. This waitlist is not directed to children under 13. See the privacy policy. Your address is stored by Buttondown (opens in a new tab), who send the mail on our behalf and show the confirmation page.

Evidence behind this page

Sources

Each evidence badge opens the source and its limits. The full list stays available here.

  1. U.S. Food and Drug AdministrationRegulatory · Regulatory / guideline, tier 1Independent source
    Published
    SteadySkin last checked
    What this source can and cannot tell you

    What this source supports

    Supports the current FDA classification of ultraviolet lamps for dermatologic disorders as Class II medical devices.

    What it does not support

    It does not validate a marketplace listing, establish that a particular unit is genuine or cleared, determine a lawful transfer pathway, or show that a used device remains serviceable.

    Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.

  2. Electronic Code of Federal RegulationsRegulatory · Regulatory / guideline, tier 1Independent source
    Published
    SteadySkin last checked
    What this source can and cannot tell you

    What this source supports

    Supports the federal prescription-device labeling and distribution framework.

    What it does not support

    It does not decide whether a specific private transaction is lawful, replace state law, authorize a seller, transfer a prescription, or establish that a used unit is safe or supported.

    Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.